1. Home
  2. SIBN vs IOVA Comparison

SIBN vs IOVA Comparison

Compare SIBN & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • IOVA
  • Stock Information
  • Founded
  • SIBN 2008
  • IOVA 2007
  • Country
  • SIBN United States
  • IOVA United States
  • Employees
  • SIBN N/A
  • IOVA N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SIBN Health Care
  • IOVA Health Care
  • Exchange
  • SIBN Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • SIBN 571.0M
  • IOVA 597.7M
  • IPO Year
  • SIBN 2018
  • IOVA N/A
  • Fundamental
  • Price
  • SIBN $18.78
  • IOVA $1.74
  • Analyst Decision
  • SIBN Strong Buy
  • IOVA Buy
  • Analyst Count
  • SIBN 5
  • IOVA 10
  • Target Price
  • SIBN $24.40
  • IOVA $12.22
  • AVG Volume (30 Days)
  • SIBN 604.0K
  • IOVA 19.7M
  • Earning Date
  • SIBN 05-05-2025
  • IOVA 05-08-2025
  • Dividend Yield
  • SIBN N/A
  • IOVA N/A
  • EPS Growth
  • SIBN N/A
  • IOVA N/A
  • EPS
  • SIBN N/A
  • IOVA N/A
  • Revenue
  • SIBN $176,601,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • SIBN $19.30
  • IOVA $83.64
  • Revenue Next Year
  • SIBN $15.28
  • IOVA $70.34
  • P/E Ratio
  • SIBN N/A
  • IOVA N/A
  • Revenue Growth
  • SIBN 22.60
  • IOVA 11070.12
  • 52 Week Low
  • SIBN $11.70
  • IOVA $1.64
  • 52 Week High
  • SIBN $20.05
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 60.13
  • IOVA 34.63
  • Support Level
  • SIBN $18.25
  • IOVA $1.71
  • Resistance Level
  • SIBN $19.09
  • IOVA $1.87
  • Average True Range (ATR)
  • SIBN 0.57
  • IOVA 0.13
  • MACD
  • SIBN -0.15
  • IOVA 0.03
  • Stochastic Oscillator
  • SIBN 26.96
  • IOVA 41.00

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: